These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Molecular pharmacology and ligand docking studies reveal a single amino acid difference between mouse and human serotonin 5-HT2A receptors that impacts behavioral translation of novel 4-phenyl-2-dimethylaminotetralin ligands. Canal CE; Cordova-Sintjago T; Liu Y; Kim MS; Morgan D; Booth RG J Pharmacol Exp Ther; 2013 Dec; 347(3):705-16. PubMed ID: 24080681 [TBL] [Abstract][Full Text] [Related]
9. Postnatal fluoxetine-evoked anxiety is prevented by concomitant 5-HT2A/C receptor blockade and mimicked by postnatal 5-HT2A/C receptor stimulation. Sarkar A; Chachra P; Vaidya VA Biol Psychiatry; 2014 Dec; 76(11):858-68. PubMed ID: 24315410 [TBL] [Abstract][Full Text] [Related]
11. A new class of 5-HT Casey AB; Mukherjee M; McGlynn RP; Cui M; Kohut SJ; Booth RG Br J Pharmacol; 2022 Jun; 179(11):2610-2630. PubMed ID: 34837227 [TBL] [Abstract][Full Text] [Related]
12. Serotonin contracts the rat mesenteric artery by inhibiting 4-aminopyridine-sensitive Kv channels via the 5-HT2A receptor and Src tyrosine kinase. Sung DJ; Noh HJ; Kim JG; Park SW; Kim B; Cho H; Bae YM Exp Mol Med; 2013 Dec; 45(12):e67. PubMed ID: 24336234 [TBL] [Abstract][Full Text] [Related]
13. Yokukansan, a traditional Japanese herbal medicine, enhances the anxiolytic effect of fluvoxamine and reduces cortical 5-HT Ohno R; Miyagishi H; Tsuji M; Saito A; Miyagawa K; Kurokawa K; Takeda H J Ethnopharmacol; 2018 Apr; 216():89-96. PubMed ID: 29382554 [TBL] [Abstract][Full Text] [Related]
14. Co-expression and in vivo interaction of serotonin1A and serotonin2A receptors in pyramidal neurons of prefrontal cortex. Amargós-Bosch M; Bortolozzi A; Puig MV; Serrats J; Adell A; Celada P; Toth M; Mengod G; Artigas F Cereb Cortex; 2004 Mar; 14(3):281-99. PubMed ID: 14754868 [TBL] [Abstract][Full Text] [Related]
15. Mechanisms Underlying Serotonergic Excitation of Callosal Projection Neurons in the Mouse Medial Prefrontal Cortex. Stephens EK; Baker AL; Gulledge AT Front Neural Circuits; 2018; 12():2. PubMed ID: 29422840 [TBL] [Abstract][Full Text] [Related]
16. Reformulating a Pharmacophore for 5-HT2A Serotonin Receptor Antagonists. Younkin J; Gaitonde SA; Ellaithy A; Vekariya R; Baki L; Moreno JL; Shah S; Drossopoulos P; Hideshima KS; Eltit JM; González-Maeso J; Logothetis DE; Dukat M; Glennon RA ACS Chem Neurosci; 2016 Sep; 7(9):1292-9. PubMed ID: 27385190 [TBL] [Abstract][Full Text] [Related]
17. Detailed Characterization of the In Vitro Pharmacological and Pharmacokinetic Properties of Jensen AA; McCorvy JD; Leth-Petersen S; Bundgaard C; Liebscher G; Kenakin TP; Bräuner-Osborne H; Kehler J; Kristensen JL J Pharmacol Exp Ther; 2017 Jun; 361(3):441-453. PubMed ID: 28360333 [TBL] [Abstract][Full Text] [Related]
18. Activation of 5-HT2A/C receptors counteracts 5-HT1A regulation of n-methyl-D-aspartate receptor channels in pyramidal neurons of prefrontal cortex. Yuen EY; Jiang Q; Chen P; Feng J; Yan Z J Biol Chem; 2008 Jun; 283(25):17194-204. PubMed ID: 18442977 [TBL] [Abstract][Full Text] [Related]
19. Neurochemical pharmacology of psychoactive substituted N-benzylphenethylamines: High potency agonists at 5-HT Eshleman AJ; Wolfrum KM; Reed JF; Kim SO; Johnson RA; Janowsky A Biochem Pharmacol; 2018 Dec; 158():27-34. PubMed ID: 30261175 [TBL] [Abstract][Full Text] [Related]
20. Support for 5-HT2C receptor functional selectivity in vivo utilizing structurally diverse, selective 5-HT2C receptor ligands and the 2,5-dimethoxy-4-iodoamphetamine elicited head-twitch response model. Canal CE; Booth RG; Morgan D Neuropharmacology; 2013 Jul; 70():112-21. PubMed ID: 23353901 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]